Emad Shash, General Manager at National Cancer Institute, Cairo University, shared on LinkedIn:
“Three Days. Three Cities. Three Countries. One Shared Mission: Advancing Cancer Care!
October 1 to 3, 2026, marked an inspiring scientific journey across Cairo, Istanbul, and Dubai, bringing together leading oncology experts and healthcare stakeholders to exchange knowledge and advance cancer care.
October 1 Cairo, Egypt
- Best of St. Gallen Africa: Joining eminent colleagues in an engaging MDT discussion on early breast cancer, exploring evidence – based treatment strategies and personalized clinical decision – making.
- Baheya Cancer Conference: Sharing the latest advances in HER2 – positive metastatic breast cancer management in 2026, highlighting evolving treatment paradigms and clinical outcomes.
October 2 Istanbul, Türkiye
At the Hikma Biotech Scientific Forum, discussing the evolving management of metastatic triple – negative breast cancer (mTNBC), emerging therapies, and practical treatment sequencing.
October 3 Dubai, UAE
At the 7th Emirates Oncology Society (EOS) Annual Conference, contributing to three scientific and strategic discussions
- Breast Cancer Track: Who can safely be spared adjuvant chemotherapy in luminal early breast cancer?
- OncoBrothers TNBC Panel: Contemporary management strategies and clinical decision-making in TNBC.
- Integrated Healthcare Management Panel: Discussing public – private partnerships, patient navigation, education, and integrated cancer care alongside regional leaders and healthcare stakeholders.
A Particularly Meaningful Moment
Beyond the scientific exchanges, I had the profound honor and privilege of delivering a tribute to the late Prof. Yasser Abdelkader, Professor of Clinical Oncology at Cairo University and a pioneer of oncology in Egypt and our region.
Having known him personally and professionally, being entrusted to speak about his extraordinary legacy was deeply emotional and meaningful.
His scientific contributions, dedication to education, and the generations he inspired will remain an enduring legacy.
My heartfelt gratitude to Prof. Humaid Al – Shamsi MB(IRL),FRCP(Lon),FRCP(Ca),FRCP(Glasgow),FACP(US), EOS, and our UAE colleagues for this touching gesture of remembrance.
My reflection:
Advancing oncology is not only about developing better treatments. It is about selecting the right treatment for the right patient, avoiding unnecessary interventions, and ensuring equitable access to scientific progress.
Sincere thanks to Prof. Hiba Gamal (Best of St. Gallen Africa), Prof. Amany Helal (Baheya), Prof. Humaid AlShamsi, and all distinguished colleagues and friends.
Special appreciation to Roche, Hikma Pharmaceuticals, MSD Gulf, and Conveners for supporting scientific education and regional collaboration.
From scientific evidence to clinical practice, from healthcare policy to patient – centered care, and from honoring our pioneers to inspiring future generations, our mission remains: Better cancer care for every patient.”
Other articles featuring Emad Shash on OncoDaily.
